Abstract
The antimalaria drug chloroquine is often taken against a background of analgesic nephropathy caused by nonsteroidal anti-inflammatory drugs such as paracetamol (acetaminophen). Chloroquine has marked effects on the normal kidney and stimulates an increase in plasma vasopressin via nitric oxide. The aim of this study was to determine the renal action of chloroquine in a model of analgesic nephropathy. Sprague-Dawley rats (n = 6–8/group) were treated with paracetamol (500 mg kg−1day−1) for 30 days in drinking water to induce analgesic nephropathy; control rats received normal tap water. Under intraval anesthesia (100 mg kg−1) rats were infused with 2.5% dextrose for 3 h to equilibrate and after a control hour they received either vehicle, chloroquine (0.04 mg h−1),Nω-nitro-l-arginine methyl ester (l-NAME, nitric-oxide synthase inhibitor, 60 μg kg−1 h−1) or combined chloroquine andl-NAME over the next hour. Plasma was collected from a parallel group of animals for vasopressin radioimmunoassay. Long-term paracetamol treatment resulted in a decrease in glomerular filtration rate (p < 0.05), sodium excretion (p < 0.001), and urine osmolality (p < 0.001), but no change in urine flow rate compared with untreated animals. Chloroquine administration in paracetamol treated rats induced a significant reduction (p < 0.05) in urine flow rate and a significant increase in plasma vasopressin (p < 0.001). These effects were blocked by coadministration of l-NAME and thus seem to be mediated by a pathway involving nitric oxide. However, these responses contrast with the chloroquine-induced diuresis previously observed in untreated rats, possibly reflecting paracetamol inhibition of renal prostaglandin synthesis and consequent moderation of vasopressin's action.
Footnotes
-
DOI: 10.1124/jpet.102.047233
- Abbreviations:
- NSAID
- nonsteroidal anti-inflammatory drug
- GFR
- glomerular filtration rate
- PGE2
- prostaglandin E2
- l-NAME
- Nω-nitro-l-arginine methyl ester
- ANOVA
- analysis of variance
- SNK
- Student-Newman-Keuls
- AVP
- vasopressin
- HETE
- hydroxyeicosatetraenoic acid
- Received November 21, 2002.
- Accepted December 18, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|